Literature DB >> 7543940

Spinal cord compression in prostate cancer.

J L Osborn1, R H Getzenberg, D L Trump.   

Abstract

Approximately 200,000 men will be diagnosed with prostate cancer in 1994. While localized disease is potentially curable with surgery or radiation therapy, metastatic disease is incurable. The most frequent site of metastasis is bone. Spinal cord compression occurs in approximately 7% of men with prostate cancer. Back pain often heralds the diagnosis of spinal cord compression. In prostate cancer patients with back pain or signs of myelopathy or radiculopathy, plain radiographs of the spine and magnetic resonance imaging should be performed. Early diagnosis is of utmost importance. The neurologic status prior to treatment is the major determinant influencing outcome. Following diagnosis, corticosteroid therapy should begin immediately. Hormonal therapy should be instituted in those patients who have not previously undergone hormonal manipulation. The standard approach to definitive therapy is radiation. Surgical decompression plays a role in patients with severe myelopathy, spinal instability, and in those patients whose neurologic status deteriorates during or after radiation therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7543940     DOI: 10.1007/bf01053418

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  50 in total

Review 1.  Spinal cord compression from epidural metastases.

Authors:  T N Byrne
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  Spinal metastases. A retrospective survey from a general hospital.

Authors:  R J Stark; R A Henson; S J Evans
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

3.  Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy.

Authors:  R F Young; E M Post; G A King
Journal:  J Neurosurg       Date:  1980-12       Impact factor: 5.115

4.  Spinal cord compression in prostate cancer. A 10-year experience.

Authors:  M A Rosenthal; D Rosen; D Raghavan; J Leicester; P Duval; M Besser; B Pearson
Journal:  Br J Urol       Date:  1992-05

5.  Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.

Authors:  J Kirchheimer; A Köller; B R Binder
Journal:  Biochim Biophys Acta       Date:  1984-02-14

6.  Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.

Authors:  M Haq; D Goltzman; G Tremblay; P Brodt
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

7.  Vertebral body resection for epidural compression by malignant tumors. Results of forty-seven consecutive operative procedures.

Authors:  T Siegal; P Tiqva; T Siegal
Journal:  J Bone Joint Surg Am       Date:  1985-03       Impact factor: 5.284

8.  Early diagnosis of spinal epidural metastases.

Authors:  L D Rodichok; G R Harper; J C Ruckdeschel; A Price; G Roberson; K D Barron; J Horton
Journal:  Am J Med       Date:  1981-06       Impact factor: 4.965

9.  Experimental spinal cord compression by epidural neoplasm.

Authors:  Y Ushio; R Posner; J B Posner; W R Shapiro
Journal:  Neurology       Date:  1977-05       Impact factor: 9.910

10.  Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype.

Authors:  F D Gaylis; H N Keer; M J Wilson; H C Kwaan; A A Sinha; J M Kozlowski
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

View more
  13 in total

1.  Spinal leptomeningeal metastases from prostate cancer.

Authors:  R Deinsberger; R Regatschnig; B Kaiser; H C Bankl
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

2.  Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone.

Authors:  Olga Zolochevska; Jayne Ellis; Sangram Parelkar; Delphine Chan-Seng; Todd Emrick; Jingna Wei; Igor Patrikeev; Massoud Motamedi; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2013-11-06       Impact factor: 5.695

Review 3.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 4.  Surgical indications and prognosis in spinal metastases.

Authors:  K Nanassis; C Alexiadou-Rudolf; J Rudolf; R A Frowein
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

5.  Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatment.

Authors:  F Kovner; S Spigel; I Rider; I Otremsky; I Ron; E Shohat; J M Rabey; J Avram; O Merimsky; N Wigler; S Chaitchik; M Inbar
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

6.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

7.  A multidisciplinary approach to the management of hormone-refractory prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

Review 8.  The role of bisphosphonates in the management of prostate cancer.

Authors:  Fred Saad
Journal:  Curr Oncol Rep       Date:  2006-05       Impact factor: 5.075

9.  Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer.

Authors:  Vidija Soerdjbalie-Maikoe; Rob C M Pelger; Guus A B Lycklama à Nijeholt; Jan-Willem Arndt; Aeilko H Zwinderman; Herman Bril; Socrates E Papapoulos; Neveen A T Hamdy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-19       Impact factor: 9.236

10.  Update in palliative management of hormone refractory cancer of prostate.

Authors:  Pratipal Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.